Log in to your Inderes Free account to see all free content on this page.

Bonesupport

188.50 SEK

+2.56 %

Less than 1K followers

BONEX

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+2.56 %

-9.64 %

-40.80 %

-29.77 %

-51.27 %

-47.20 %

+122.03 %

+149.34 %

+489.06 %

Bonesupport operates in the medical technology industry and focuses on the development and manufacture of bioceramic implants for bone repair and reconstruction. The company's products are aimed at surgeons and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. Bonesupport was founded in 1999 and is headquartered in Lund, Sweden.

Market cap

12.59B SEK

Turnover

64.81M SEK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

24.2.

2026

Annual report '25

22.4.

2026

Interim report Q1'26

12.5.

2026

General meeting '26

All

Webcasts

Press releases

ShowingAll content types

Regulatory press release12/2/2025, 7:13 AM

CERAMENT® V application in the U.S. transferred to the De Novo process

Press release10/31/2025, 3:40 PM

BONESUPPORT HOLDING AB (publ) – Correction in Q3 2025 interim report

Press release10/24/2025, 7:12 AM

Redeye: BONESUPPORT (Q3 Review) - Still just getting started

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Bonesupport, Audiocast, Q3'25

Webcast10/23/2025, 8:00 AM

Bonesupport, Audiocast, Q3'25

Regulatory press release10/23/2025, 6:00 AM

BONESUPPORT HOLDING AB (publ) – publishes Q3 2025 Interim report

Press release10/20/2025, 12:15 PM

Modular Finance IR Consensus: BONESUPPORT – Consensus estimates Q3 2025

Press release10/16/2025, 6:00 AM

BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q3 2025

Press release9/16/2025, 6:50 AM

No infection recurrence when using CERAMENT® G in infected hip implant management

Press release9/15/2025, 7:40 AM

Strong CERAMENT® Results Presented at EBJIS

Regulatory press release8/12/2025, 2:51 PM

CMS APPROVES NTAP FOR CERAMENT® G IN OPEN FRACTURES, PROVIDING ADDITIONAL HOSPITAL REIMBURSEMENT STARTING OCTOBER 1, 2025

Press release7/30/2025, 7:42 AM

ANNOUNCED INSIDER TRADING

Press release7/16/2025, 8:20 AM

Redeye: BONESUPPORT Q2 - Still puttin’ on the ritz

Bonesupport, Audiocast, Q2'25

Webcast7/15/2025, 8:00 AM

Bonesupport, Audiocast, Q2'25

Regulatory press release7/15/2025, 6:00 AM

BONESUPPORT HOLDING AB (publ) – publishes Q2 2025 Interim report

Press release7/10/2025, 12:30 PM

Modular Finance IR Consensus: BONESUPPORT – Consensus estimates Q2 2025

Press release7/8/2025, 6:00 AM

BONESUPPORT HOLDING AB (publ) – Invitation to conference call and webcast for Interim report Q2 2025

Press release6/5/2025, 9:22 AM

BONESUPPORT’s incoming CEO acquires shares

Regulatory press release5/27/2025, 2:00 PM

BULLETIN FROM THE ANNUAL SHAREHOLDERS’ MEETING IN BONESUPPORT HOLDING AB ON 27 MAY 2025

Regulatory press release4/28/2025, 6:05 AM

Upcoming CEO change. Emil Billbäck will transfer to a role as Senior Advisor. Torbjörn Sköld will start as CEO effective September 1st, 2025

Press release4/25/2025, 7:45 AM

Redeye: BONESUPPORT Q1 - Bulldozers will bulldoze

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.